Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia chromosome (Ph) that results from BCR-ABL1 rearrangement. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.